Follow-up studies further demonstrated that fractionated radiotherapy in combination with anti-CTLA-4 treatment induced a more significant systemic antitumor effect in a mouse breast cancer model compared with single-dose radiotherapy[78,79]. The gene discussed is CTLA4; the disease is breast carcinoma.